Jolmo Capital
Jolmo Capital provides related capital management and advisory services.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Jolmo Capital Information
Geographic Data
Address: Nanda Soft Science and Technology Innovation Park, 19 Qingjiang South Road
City: Nanjing
State: jiangsu province
Zip: 211100
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Jolmo Capital is an investment firm that provides related capital management and advisory services to new industries. As a diversified firm, Jolmo helps assist enterprises with rapid growth primarily through venture capital and in collaboration with other financial instruments. Jolmo Capital was founded in 2004 and is based in Nanjing, Jiangsu Province in China.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2013 | Dashi Jiuxin | Venture Round | 4.9M |
| 7/2022 | Oriental Bacteria | Series A | - |
| 8/2015 | MFK.com | Angel Round | 3.9M |
| 1/2022 | BM001 | Series A | 12.6M |
| 6/2021 | Simcere Pharma | Series B | 0 |
| 4/2022 | VSWORK | Seed Round | - |
| 3/2010 | Senyint | Angel Round | - |
| 1/2018 | Senyint | Series D | - |
| 4/2015 | LDD Liduoduo | Series B | 16.2M |
| 8/2022 | Guangdong Gaojing Solar Energy Technology | Series B | 0 |
| 11/2017 | ZUNSION | Post-IPO Equity | 6M |
| 2/2019 | Yunji Technology | Series B | - |
| 9/2022 | Puncture Robotic | Series A | - |
| 12/2022 | Tsingke Biotechnology | Series B | 0 |
| 8/2015 | DynoSense | Series A | 0 |
| 3/2022 | PowerValue | Seed Round | 1.6M |
| 12/2006 | Jiangsu Shunda Semiconductor Development | Private Equity Round | 0 |
| 6/2019 | Star chain technology | Seed Round | 0 |
| 9/2018 | Letsiot.com | Corporate Round | - |
| 11/2022 | Soundec | Series B | - |
| 10/2014 | DAYANG PARKING | Series B | 3.3M |
| 1/2016 | Youyi CARE | Series A | 1.8M |
| 2/2017 | Rixing Bio-Tech | Post-IPO Equity | 14.9M |
| 11/2021 | Help Stem Cell Innovations | Series C | 0 |
| 7/2020 | SHINEKING BIOTECH | Series B | 0 |
| 10/2016 | Jiankang 724 | Series A | 7.4M |
| 7/2019 | Lumigenex | Venture Round | 373.5k |
| 7/2022 | Oriental Bacteria | Series A | - |
| 4/2022 | VSWORK | Seed Round | - |
| 3/2022 | PowerValue | Seed Round | 0 |
| 1/2022 | BM001 | Series A | 0 |
| 11/2021 | Help Stem Cell Innovations | Series C | 0 |
| 6/2021 | Simcere Pharma | Series B | 0 |
| 7/2020 | SHINEKING BIOTECH | Series B | 0 |
| 7/2019 | Lumigenex | Venture Round | 0 |
| 6/2019 | Star chain technology | Seed Round | 0 |
| 2/2019 | Yunji Technology | Series B | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
